Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan D Anker

Showing results (1-10 of 1,301) with videos related to

Pageof 131
Sort By:
European Journal of Heart Failure|June 9, 2004
Efficacy of a homeopathic Crataegus preparationStefan D Anker
International Journal of Cardiology|August 7, 2002
Cachexia: time to receive more attentionStefan D Anker
Heart Failure Monitor|March 18, 2003
Meeting report from the 74th annual scientific sessions of the American Heart Association (AHA). Anaheim, CA, USA, November 11-14, 2001Wolfram Doehner, Stefan D Anker
Seminars in Nephrology|January 22, 2005
Uric acid in chronic heart failureWolfram Doehner, Stefan D Anker
Herz|April 17, 2009
Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systemsMitja Lainscak, Stefan D Anker
Lancet (London, England)|February 18, 2010
Liraglutide for weight loss in obese peopleThomas Thum, Stefan D Anker
Expert Opinion on Drug Discovery|July 25, 2012
The underestimated impact of cachexiaJochen Springer, Stefan D Anker
Journal of Cardiac Failure|May 8, 2010
Anaerobic threshold: teaching material and not prognostic parameterDirk Habedank, Stefan D Anker
NDT Plus|May 23, 2009
Future perspectives on treatment with erythropoiesis-stimulating agents in high-risk patientsStefan D Anker, Robert Toto
ESC Heart Failure|July 20, 2018
Empagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzleStefan D Anker, Javed Butler
Pageof 131

Showing results (1-10 of 1,301) with videos related to

Sort By:
Pageof 131
European Journal of Heart Failure|June 9, 2004
Efficacy of a homeopathic Crataegus preparationStefan D Anker
International Journal of Cardiology|August 7, 2002
Cachexia: time to receive more attentionStefan D Anker
Heart Failure Monitor|March 18, 2003
Meeting report from the 74th annual scientific sessions of the American Heart Association (AHA). Anaheim, CA, USA, November 11-14, 2001Wolfram Doehner, Stefan D Anker
Seminars in Nephrology|January 22, 2005
Uric acid in chronic heart failureWolfram Doehner, Stefan D Anker
Herz|April 17, 2009
Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systemsMitja Lainscak, Stefan D Anker
Lancet (London, England)|February 18, 2010
Liraglutide for weight loss in obese peopleThomas Thum, Stefan D Anker
Expert Opinion on Drug Discovery|July 25, 2012
The underestimated impact of cachexiaJochen Springer, Stefan D Anker
Journal of Cardiac Failure|May 8, 2010
Anaerobic threshold: teaching material and not prognostic parameterDirk Habedank, Stefan D Anker
NDT Plus|May 23, 2009
Future perspectives on treatment with erythropoiesis-stimulating agents in high-risk patientsStefan D Anker, Robert Toto
ESC Heart Failure|July 20, 2018
Empagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzleStefan D Anker, Javed Butler
Pageof 131